Related Experiment Videos
Two CD34+ stem cells from umbilical cord blood enrichment methods
C Pafumi1, P Bosco, A Cavallaro
1Institute of Obstetrics and Gynaecology, University of Catania, Italy. pafumi@mbox.unict.it
Pediatric Hematology and Oncology
|June 8, 2002
Summary
Early umbilical cord clamping and the Mini Macs system yield superior CD34+ stem cell recovery. This method enhances stem cell quantity and quality for potential adult engraftment, improving transplant outcomes.
Area of Science:
- Hematology
- Stem Cell Biology
- Transplantation Medicine
Background:
- Umbilical cord blood (UCB) is a valuable source of hematopoietic stem cells.
- Optimizing UCB collection and processing is crucial for successful transplantation.
- Current methods for stem cell enrichment have varying efficiencies.
Purpose of the Study:
- To evaluate the impact of umbilical cord clamping time on UCB volume and CD34+ stem cell yield.
- To compare the efficacy of two stem cell enrichment systems (Stem-Sep and Mini-MACS) for UCB.
- To determine the optimal method for obtaining high-quality, high-proliferative CD34+ stem cells for transplantation.
Main Methods:
- UCB was collected after delivery, with variations in clamping time.
- Two stem cell enrichment methods were employed: Stem-Sep (negative selection) and Mini-MACS (positive selection for CD34+ cells).
- Collected stem cells were assessed for recovery, purity, and clonogenic activity.
Main Results:
- The Mini-MACS system demonstrated superior recovery (54% colonies, 90% purity) compared to Stem-Sep (35% colonies, 80% purity).
- Earlier umbilical cord clamping correlated with increased UCB volume and higher CD34+ stem cell yield and clonogenic activity.
- The Mini-MACS system showed an inverse relationship between clamping time and hematopoietic progenitor recovery.
Conclusions:
- Early umbilical cord clamping and the Mini-MACS enrichment system maximize CD34+ stem cell recovery and quality.
- This optimized approach increases the potential for successful adult engraftment from UCB.
- Enhanced stem cell yield may reduce graft-versus-host disease and improve survival rates in adult stem cell transplantation.